mim8
mAbexperimentalBi-specific
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Nov 17, 2021 (NCT05127473)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor IXAGONIST
F9 agonist
- Coagulation factor XAGONIST
F10 agonist
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05685238 | Phase 3 | Feb 13, 2023 | Novo Nordisk |
| NCT05306418 | Phase 3 | Apr 4, 2022 | Novo Nordisk |
| NCT05127473 | Phase 1 | Nov 17, 2021 | Novo Nordisk |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novo Nordisk | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1